Peptide United

Research Tool

Compare Peptides

Select two peptides to view a side-by-side breakdown of their profiles, mechanisms, and research data.

AOD-9604

Anti-Obesity Drug 9604 · hGH Fragment 177-191

Semaglutide

Ozempic · Wegovy · Rybelsus

Research Status
Phase III
Approved
Half-Life
~30 minutes
~1 week (allows once-weekly dosing)
Mol. Weight
Admin Routes
subcutaneous, oral
subcutaneous, oral
Categories
Fat Loss & Metabolic
GLP-1 & Metabolic Hormones, Fat Loss & Metabolic, Cardiovascular
Mechanism
Pharmacokinetics
Research Findings
Safety